These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21952740)

  • 1. Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.
    Plant D; Prajapati R; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Arthritis Rheum; 2012 Mar; 64(3):665-70. PubMed ID: 21952740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.
    Cui J; Saevarsdottir S; Thomson B; Padyukov L; van der Helm-van Mil AH; Nititham J; Hughes LB; de Vries N; Raychaudhuri S; Alfredsson L; Askling J; Wedrén S; Ding B; Guiducci C; Wolbink GJ; Crusius JB; van der Horst-Bruinsma IE; Herenius M; Weinblatt ME; Shadick NA; Worthington J; Batliwalla F; Kern M; Morgan AW; Wilson AG; Isaacs JD; Hyrich K; Seldin MF; Moreland LW; Behrens TW; Allaart CF; Criswell LA; Huizinga TW; Tak PP; Bridges SL; Toes RE; Barton A; Klareskog L; Gregersen PK; Karlson EW; Plenge RM
    Arthritis Rheum; 2010 Jul; 62(7):1849-61. PubMed ID: 20309874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.
    Ferreiro-Iglesias A; Montes A; Perez-Pampin E; Cañete JD; Raya E; Magro-Checa C; Vasilopoulos Y; Sarafidou T; Caliz R; Ferrer MA; Joven B; Carreira P; Balsa A; Pascual-Salcedo D; Blanco FJ; Moreno-Ramos MJ; Fernández-Nebro A; Ordóñez MC; Alegre-Sancho JJ; Narváez J; Navarro-Sarabia F; Moreira V; Valor L; García-Portales R; Marquez A; Martin J; Gómez-Reino JJ; Gonzalez A
    Pharmacogenomics J; 2016 Apr; 16(2):137-40. PubMed ID: 25896535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between PTPRC rs10919563 A/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC
    Rheumatol Int; 2016 Jun; 36(6):837-44. PubMed ID: 27074847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapy.
    Canhão H; Rodrigues AM; Santos MJ; Carmona-Fernandes D; Bettencourt BF; Cui J; Rocha FL; Canas Silva J; Polido-Pereira J; Pereira Silva JA; Costa JA; Araujo D; Silva C; Santos H; Duarte C; Cáliz R; Filipescu I; Pimentel-Santos F; Branco J; Sainz J; Plenge RM; Solomon DH; Bruges-Armas J; Da Silva JA; Fonseca JE; Karlson EW
    Biomed Res Int; 2015; 2015():490295. PubMed ID: 25834819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
    Tan RJ; Gibbons LJ; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Ann Rheum Dis; 2010 Jun; 69(6):1029-35. PubMed ID: 20444755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients.
    Coulthard LR; Taylor JC; Eyre S; ; Robinson JI; Wilson AG; Isaacs JD; Hyrich K; Emery P; Barton A; Barrett JH; Morgan AW; McDermott MF
    Ann Rheum Dis; 2011 Jan; 70(1):98-103. PubMed ID: 20805296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association of variants previously associated with anti-TNF medication response in rheumatoid arthritis patients: results from a homogeneous Greek population.
    Zervou MI; Myrthianou E; Flouri I; Plant D; Chlouverakis G; Castro-Giner F; Rapsomaniki P; Barton A; Boumpas DT; Sidiropoulos P; Goulielmos GN
    PLoS One; 2013; 8(9):e74375. PubMed ID: 24040234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment.
    Mathews RJ; Robinson JI; Battellino M; Wong C; Taylor JC; ; Eyre S; Churchman SM; Wilson AG; Isaacs JD; Hyrich K; Barton A; Plant D; Savic S; Cook GP; Sarzi-Puttini P; Emery P; Barrett JH; Morgan AW; McDermott MF
    Ann Rheum Dis; 2014 Jun; 73(6):1202-10. PubMed ID: 23687262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
    Potter C; Cordell HJ; Barton A; Daly AK; Hyrich KL; Mann DA; Morgan AW; Wilson AG; ; Isaacs JD
    Ann Rheum Dis; 2010 Jul; 69(7):1315-20. PubMed ID: 20448286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study.
    Suarez-Gestal M; Perez-Pampin E; Calaza M; Gomez-Reino JJ; Gonzalez A
    Arthritis Res Ther; 2010; 12(2):R72. PubMed ID: 20423481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.
    Márquez A; Ferreiro-Iglesias A; Dávila-Fajardo CL; Montes A; Pascual-Salcedo D; Perez-Pampin E; Moreno-Ramos MJ; García-Portales R; Navarro F; Moreira V; Magro C; Caliz R; Ferrer MA; Alegre-Sancho JJ; Joven B; Carreira P; Balsa A; Vasilopoulos Y; Sarafidou T; Cabeza-Barrera J; Narvaez J; Raya E; Cañete JD; Fernández-Nebro A; Ordóñez Mdel C; de la Serna AR; Magallares B; Gomez-Reino JJ; González A; Martín J
    Arthritis Res Ther; 2014 Mar; 16(2):R66. PubMed ID: 24612463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.
    Iannaccone CK; Lee YC; Cui J; Frits ML; Glass RJ; Plenge RM; Solomon DH; Weinblatt ME; Shadick NA
    Rheumatology (Oxford); 2011 Jan; 50(1):40-6. PubMed ID: 20847201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study.
    Canet LM; Filipescu I; Cáliz R; Lupiañez CB; Canhão H; Escudero A; Segura-Catena J; Soto-Pino MJ; Ferrer MA; García A; Romani L; Pérez-Pampin E; González-Utrilla A; López Nevot MA; Collantes E; Fonseca JE; Sainz J
    Pharmacogenet Genomics; 2015 Jul; 25(7):323-33. PubMed ID: 25850964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response.
    Viatte S; Plant D; Han B; Fu B; Yarwood A; Thomson W; Symmons DP; Worthington J; Young A; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; Raychaudhuri S; Barton A
    JAMA; 2015 Apr; 313(16):1645-56. PubMed ID: 25919528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.
    Honne K; Hallgrímsdóttir I; Wu C; Sebro R; Jewell NP; Sakurai T; Iwamoto M; Minota S; Jawaheer D
    Arthritis Res Ther; 2016 Jan; 18():12. PubMed ID: 26776603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.
    Plant D; Bowes J; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; ; Barton A
    Arthritis Rheum; 2011 Mar; 63(3):645-53. PubMed ID: 21061259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.
    Bek S; Bojesen AB; Nielsen JV; Sode J; Bank S; Vogel U; Andersen V
    Pharmacogenomics J; 2017 Oct; 17(5):403-411. PubMed ID: 28607508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.
    Umiċeviċ Mirkov M; Cui J; Vermeulen SH; Stahl EA; Toonen EJ; Makkinje RR; Lee AT; Huizinga TW; Allaart R; Barton A; Mariette X; Miceli CR; Criswell LA; Tak PP; de Vries N; Saevarsdottir S; Padyukov L; Bridges SL; van Schaardenburg DJ; Jansen TL; Dutmer EA; van de Laar MA; Barrera P; Radstake TR; van Riel PL; Scheffer H; Franke B; Brunner HG; Plenge RM; Gregersen PK; Guchelaar HJ; Coenen MJ
    Ann Rheum Dis; 2013 Aug; 72(8):1375-81. PubMed ID: 23233654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.
    Sode J; Vogel U; Bank S; Andersen PS; Thomsen MK; Hetland ML; Locht H; Heegaard NH; Andersen V
    PLoS One; 2014; 9(6):e100361. PubMed ID: 24967817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.